928063-50-7Relevant academic research and scientific papers
HEPATITIS C INHIBITOR COMPOUNDS
-
Page/Page column 67-68, (2010/04/27)
Compounds of Formula (I): wherein B, R3, L0, L1, R2, Rc and R1 are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection. In particular, the present invention provides novel peptide analogs, pharmaceutical compositions containing such analogs, and uses of these analogs in the treatment of HCV infection
INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS
-
Page/Page column 465, (2008/12/07)
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.
INHIBITORS OF SERINE PROTEASES
-
Page/Page column 295-296, (2010/11/26)
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
